People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cambridge Heart Inc | — | Biotechnology | Seed | $10.2M | $130.5M | 2009 |
Richard J. Cohen, M.D., Ph.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard J. Cohen, M.D., Ph.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Roderick De Greef | 1 | 4 |
| Ali Haghighi-Mood, Ph.D. | 1 | 2 |
| John F. McGuire | 1 | 1 |
| Vincenzo LiCausi | 1 | 1 |
| Paul McCormick | 1 | 1 |
| Roderick F. De Greef | 1 | 1 |
| Kenneth V. Hachikian | 1 | 1 |
| Reed F. Malleck | 1 | 1 |
| Jeffrey F. Wiggins | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.